Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.69 USD | +0.88% | +2.83% | +243.12% |
Business Summary
Number of employees: 50
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kevin Lind
CEO | Chief Executive Officer | 47 | 20-01-02 |
Brandi Roberts
DFI | Director of Finance/CFO | 50 | 20-12-31 |
Chief Tech/Sci/R&D Officer | - | - | |
Dewey McLin
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | - | - | |
Randall Kaye
CTO | Chief Tech/Sci/R&D Officer | 61 | 22-03-20 |
Julie Baker
PRN | Corporate Officer/Principal | - | 22-12-31 |
Gus Cardenas
PRN | Corporate Officer/Principal | - | - |
Anne Danks
PRN | Corporate Officer/Principal | - | - |
Marco Peters
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CHM | Chairman | 65 | 20-11-30 |
Director/Board Member | 67 | 20-11-30 | |
Vincent Aurentz
BRD | Director/Board Member | 56 | 20-01-31 |
Casey Lynch
BRD | Director/Board Member | 50 | 21-01-31 |
Kevin Lind
CEO | Chief Executive Officer | 47 | 20-01-02 |
Corinne Le Goff
BRD | Director/Board Member | 58 | 21-02-28 |
Jane Tiller
BRD | Director/Board Member | 64 | 21-11-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 5,270,755 | 0 | 0 | 85.50 % |
Stock B | 1 | 33,609,299 | 33,242,929 ( 98.91 %) | 0 |
Company contact information
Longboard Pharmaceuticals, Inc.
4275 Executive Square Suite 950
92037, La Jolla
+
http://www.longboardpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+243.12% | 797M | |
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |
- Stock Market
- Equities
- LBPH Stock
- Company Longboard Pharmaceuticals, Inc.